tranexamic acid has been researched along with Aortic Aneurysm in 12 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Aortic Aneurysm: An abnormal balloon- or sac-like dilatation in the wall of AORTA.
Excerpt | Relevance | Reference |
---|---|---|
"The management of chronic disseminated intravascular coagulation (DIC) caused by aortic dissection has not yet been established." | 5.46 | Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years. ( Adachi, T; Gatate, Y; Kawamura, A; Masaki, N; Namba, T; Sato, A; Yada, H; Yasuda, R, 2017) |
" We present a case of postmenopausal bleeding, because of chronic DIC, which resulted from aortic aneurysm and was managed with replacement blood products and tranexamic acid." | 3.72 | Postmenopausal bleeding due to chronic DIC. ( Bollapragada, SS; Garg, M; McFarlane, T, 2004) |
"Tranexamic acid treatment was without side effects and was given in standard doses until closure of the aneurysm or alternatively up to three days after the initial bleeding." | 2.43 | ["Ultra-early" antifibrinolytic treatment of subarachnoidal bleeding with tranexamic acid]. ( Astrup, J, 2006) |
"The management of chronic disseminated intravascular coagulation (DIC) caused by aortic dissection has not yet been established." | 1.46 | Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years. ( Adachi, T; Gatate, Y; Kawamura, A; Masaki, N; Namba, T; Sato, A; Yada, H; Yasuda, R, 2017) |
"Enhanced CT revealed type-A acute aortic dissection." | 1.28 | [A case of medically treated type A acute aortic dissection: trial of antifibrinolytic therapy while monitoring the thrombotic and fibrinolytic parameters]. ( Hamanaka, S; Hata, T; Murakami, T; Namba, H; Shinozaki, M; Sone, Y; Taniguchi, G; Tezuka, M; Tsushima, Y, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 2 (16.67) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 3 (25.00) | 2.80 |
Authors | Studies |
---|---|
Monaco, F | 1 |
Nardelli, P | 1 |
Pasin, L | 1 |
Barucco, G | 1 |
Mattioli, C | 1 |
Di Tomasso, N | 1 |
Dalessandro, G | 1 |
Giardina, G | 1 |
Landoni, G | 2 |
Chiesa, R | 1 |
Zangrillo, A | 2 |
Bolliger, D | 2 |
Tanaka, KA | 2 |
Yamada, S | 1 |
Asakura, H | 1 |
Gatate, Y | 1 |
Masaki, N | 1 |
Sato, A | 1 |
Yasuda, R | 1 |
Namba, T | 1 |
Yada, H | 1 |
Kawamura, A | 1 |
Adachi, T | 1 |
Silvetti, S | 1 |
Crivellari, M | 1 |
Castiglioni, A | 1 |
Alfieri, O | 1 |
Koster, A | 1 |
Faraoni, D | 1 |
Kimura, SI | 1 |
Odawara, J | 1 |
Aoki, T | 1 |
Yamakura, M | 1 |
Takeuchi, M | 1 |
Watanabe, Y | 1 |
Matsue, K | 1 |
Diplaris, KT | 1 |
Karfis, EA | 1 |
Ampatzidou, F | 1 |
Ananiadou, OG | 1 |
Vakalopoulou, S | 1 |
Madesis, A | 1 |
Asteri, T | 1 |
Drossos, G | 1 |
Bollapragada, SS | 1 |
Garg, M | 1 |
McFarlane, T | 1 |
Astrup, J | 1 |
Tsushima, Y | 1 |
Hata, T | 1 |
Namba, H | 1 |
Sone, Y | 1 |
Tezuka, M | 1 |
Shinozaki, M | 1 |
Murakami, T | 1 |
Hamanaka, S | 1 |
Taniguchi, G | 1 |
Takada, A | 1 |
Takada, Y | 1 |
Mori, T | 1 |
Sakaguchi, S | 1 |
Tomeoku, M | 1 |
Nakase, T | 1 |
Morita, K | 1 |
Katou, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
TRACE STUDY: A Randomized Controlled Trial Using Tranexamic Acid in the Treatment of Subdural Hematoma[NCT05713630] | Phase 3 | 130 participants (Anticipated) | Interventional | 2024-03-31 | Not yet recruiting | ||
Tranexamic Acid in Major Vascular Surgery. A Randomized Placebo-controlled Trial.[NCT02335359] | Phase 4 | 100 participants (Actual) | Interventional | 2015-03-04 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for tranexamic acid and Aortic Aneurysm
Article | Year |
---|---|
Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.
Topics: Administration, Oral; Aged; Aged, 80 and over; alpha-2-Antiplasmin; Anticoagulants; Antifibrinolytic | 2021 |
["Ultra-early" antifibrinolytic treatment of subarachnoidal bleeding with tranexamic acid].
Topics: Aneurysm, Ruptured; Antifibrinolytic Agents; Aortic Aneurysm; Denmark; Early Diagnosis; Emergencies; | 2006 |
1 trial available for tranexamic acid and Aortic Aneurysm
Article | Year |
---|---|
Tranexamic acid in open aortic aneurysm surgery: a randomised clinical trial.
Topics: Aged; Antifibrinolytic Agents; Aortic Aneurysm; Blood Loss, Surgical; Blood Transfusion; Cardiac Sur | 2020 |
Tranexamic acid in open aortic aneurysm surgery: a randomised clinical trial.
Topics: Aged; Antifibrinolytic Agents; Aortic Aneurysm; Blood Loss, Surgical; Blood Transfusion; Cardiac Sur | 2020 |
Tranexamic acid in open aortic aneurysm surgery: a randomised clinical trial.
Topics: Aged; Antifibrinolytic Agents; Aortic Aneurysm; Blood Loss, Surgical; Blood Transfusion; Cardiac Sur | 2020 |
Tranexamic acid in open aortic aneurysm surgery: a randomised clinical trial.
Topics: Aged; Antifibrinolytic Agents; Aortic Aneurysm; Blood Loss, Surgical; Blood Transfusion; Cardiac Sur | 2020 |
9 other studies available for tranexamic acid and Aortic Aneurysm
Article | Year |
---|---|
Tranexamic acid in vascular surgery: antifibrinolytic or clot-stabilising activity.
Topics: Antifibrinolytic Agents; Aortic Aneurysm; Humans; Thrombosis; Tranexamic Acid; Vascular Surgical Pro | 2020 |
Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years.
Topics: Aged; Antifibrinolytic Agents; Aortic Aneurysm; Aortic Dissection; Chronic Disease; Disseminated Int | 2017 |
CASE 12-2016 Ascending Aorta Dissection in a Jehovah's Witness Patient on Warfarin.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Aorta; Aortic Aneurysm; Aortic Dissection; Blood Coag | 2016 |
Use of tranexamic acid for disseminated intravascular coagulation with excessive fibrinolysis associated with aortic dissection in a patient with chronic renal failure.
Topics: Aged; Aortic Aneurysm; Disseminated Intravascular Coagulation; Fibrinolysis; Humans; Kidney Failure, | 2009 |
Acute type-a dissection in a patient with severe hemophilia A.
Topics: Acute Disease; Aortic Aneurysm; Aortic Dissection; Factor VIII; Hemophilia A; Humans; Male; Middle A | 2012 |
Postmenopausal bleeding due to chronic DIC.
Topics: Aged; Aortic Aneurysm; Blood Transfusion; Chronic Disease; Disseminated Intravascular Coagulation; F | 2004 |
[A case of medically treated type A acute aortic dissection: trial of antifibrinolytic therapy while monitoring the thrombotic and fibrinolytic parameters].
Topics: Acute Disease; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; Aortic Aneurysm; Aort | 1992 |
Prevention of severe bleeding by tranexamic acid in a patient with disseminated intravascular coagulation.
Topics: Aged; alpha-Macroglobulins; Aorta, Abdominal; Aortic Aneurysm; Cyclohexanecarboxylic Acids; Dissemin | 1990 |
[Chronic disseminated intravascular coagulation due to abdominal true aneurysm in two cases--effect of anti-platelet and anti-fibrinolytic therapy].
Topics: Aged; Aorta, Abdominal; Aortic Aneurysm; Chronic Disease; Cyclohexanecarboxylic Acids; Disseminated | 1989 |